Showing results (1081-1090 of 1,142) with videos related to
Sort By:
Pageof 115
Breast Cancer Research and Treatment|March 18, 2008
Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patientsNan-Yan Rao, Zhen Hu, Wen-Feng Li, et al.The Lancet Regional Health. Western Pacific|July 30, 2021
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trialKe-Da Yu, Xi-Yu Liu, Li Chen, et al.Cell Reports|March 9, 2022
Tumor-derived Jagged1 promotes cancer progression through immune evasionJingjing Meng, Yi-Zhou Jiang, Shen Zhao, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 4, 2007
[Incidence rates of human immunodeficiency virus and syphilis as well as the rate of retention in a 6-month follow-up study of female sex workers in areas with heavy drug use in Xichang of Sichuan province, China]Li-Guang Tian, Ze-En Ma, Yu-Hua Ruan, et al.Emerging Infectious Diseases|October 19, 2005
Molecular epidemiology of SARS-associated coronavirus, BeijingWei Liu, Fang Tang, Arnaud Fontanet, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2019
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast CancerYi Xiao, Ding Ma, Shen Zhao, et al.Science Bulletin|January 12, 2025
Tumor cell-derived N-acetyl-aspartyl-glutamate reshapes the tumor microenvironment to facilitate breast cancer metastasisJie Xia, Lixing Zhang, Wucheng Zhu, et al.Head & Neck|June 10, 2024
Prognostic utility of the geriatric nutritional risk index for head and neck cancer: Systematic review and meta-analysisYao-Te Tsai, Liang-Tseng Kuo, Yun-Ting Wang, et al.Nature Medicine|June 25, 2025
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trialSong-Yang Wu, Xi Jin, Yin Liu, et al.Cell Research|September 5, 2019
Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancersDaisong Wang, Xin Hu, Chunye Liu, et al.Pageof 115